Source: International Congress 2016 – Clinic of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Alice Huertas (Paris, France), Alice Huertas, Ly Tu, Raphael Thuillet, Carole Phan, Jennifer Bordenave, Morane Le Hiress, Roland Jovan, Florence Parent, Gérald Simonneau, David Montani, Marc Humbert, Christophe Guignabert. Changes in red blood cell membrane structure in pulmonary arterial hypertension. Eur Respir J 2016; 48: Suppl. 60, 260

Member's Comments

No comment yet.

Related content which might interest you: Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Is the increase in NO lung transfer due to free plasmatic hemoglobin in pulmonary arterial hypertension? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Sildenafil improves heart rate variability, pulmonary hemodynamics and functional status in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Characterization of circulating CD133+ progenitor cells in pulmonary arterial hypertension Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Comparison of current therapies against endothelin-induced growth in pulmonary smooth arterial muscle cells (PASMCs) derived from patients with pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Increased Cyr61 in pulmonary arterial hypertension involving in proliferation of pulmonary arterial smooth muscle cells Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Endothelial cell mechanics are altered in pulmonary arterial hypertension (PAH) Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Impact of borderline pulmonary arterial pressure on survival Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Pulmonary functions and arterial blood gases in portal hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 522s Year: 2001 Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH) Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 MIF/CD74 contributes to the endothelial pro-inflammatory phenotype in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Assessment of platelet dysfunction in patients with pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Pregnancy and pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Uric acid causes excessive pulmonary arterial smooth muscle cell proliferation via URATv1 upregulation in pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Time-resolved study of endothelial shear-responsiveness in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015